Infection and antibiotic use in infancy and risk of childhood obesity: a longitudinal birth cohort study (Q38798457)

6 September 2017

Infection and antibiotic use in infancy and risk of childhood obesity: a longitudinal birth cohort study (English)

1 reference

6 September 2017

1 reference

1 reference

1 reference

De-Kun Li

1

1 reference

6 September 2017

Hong Chen

series ordinal

2

1 reference

6 September 2017

Jeannette Ferber

series ordinal

3

1 reference

6 September 2017

Roxana Odouli

series ordinal

4

1 reference

6 September 2017

1 November 2016

1 reference

The Lancet: Diabetes & Endocrinology

6 September 2017

1 reference

6 September 2017

5

1 reference

6 September 2017

18-25

1 reference

6 September 2017

1

1 reference

Mechanistic links between gut microbial community dynamics, microbial functions and metabolic health

6 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930281-9

7 January 2021

A possible link between early probiotic intervention and the risk of neuropsychiatric disorders later in childhood: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930281-9

7 January 2021

Influence of the human intestinal microbiome on obesity and metabolic dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930281-9

7 January 2021

Gut microbiome and metabolic diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930281-9

7 January 2021

Expert committee recommendations regarding the prevention, assessment, and treatment of child and adolescent overweight and obesity: summary report

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930281-9

7 January 2021

Altering the Intestinal Microbiota during a Critical Developmental Window Has Lasting Metabolic Consequences

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930281-9

7 January 2021

Childhood overweight after establishment of the gut microbiota: the role of delivery mode, pre-pregnancy weight and early administration of antibiotics.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930281-9

7 January 2021

Infant antibiotic exposures and early-life body mass

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930281-9

7 January 2021

Association of antibiotics in infancy with early childhood obesity

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930281-9

7 January 2021

Antibiotic exposure in infancy and risk of being overweight in the first 24 months of life

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930281-9

7 January 2021

Antibiotic treatment during infancy and increased body mass index in boys: an international cross-sectional study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930281-9

7 January 2021

Infant antibiotic exposure and the development of childhood overweight and central adiposity.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930281-9

7 January 2021

Antibiotic Exposure During the First 6 Months of Life and Weight Gain During Childhood

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930281-9

7 January 2021

External influence of early childhood establishment of gut microbiota and subsequent health implications.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930281-9

7 January 2021

A framework for identification of infections that contribute to human obesity

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930281-9

7 January 2021

Influenza Virus Affects Intestinal Microbiota and Secondary Salmonella Infection in the Gut through Type I Interferons

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930281-9

7 January 2021

The emerging role of interferon regulatory factor 9 in the antiviral host response and beyond

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930281-9

7 January 2021

Respiratory influenza virus infection induces intestinal immune injury via microbiota-mediated Th17 cell-dependent inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930281-9

7 January 2021

The gut microbiota and host health: a new clinical frontier

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930281-9

7 January 2021

Intestinal microbiota and type 2 diabetes: from mechanism insights to therapeutic perspective

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930281-9

7 January 2021

Effectiveness of seasonal trivalent influenza vaccine for preventing influenza virus illness among pregnant women: a population-based case-control study during the 2010-2011 and 2011-2012 influenza seasons

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930281-9

7 January 2021

Severity of influenza and noninfluenza acute respiratory illness among pregnant women, 2010-2012.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930281-9

7 January 2021

Influence of H7N9 virus infection and associated treatment on human gut microbiota

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930281-9

7 January 2021

Temporal response of the human virome to immunosuppression and antiviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930281-9

7 January 2021

The bacteriome-mycobiome interaction and antifungal host defense

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930281-9

7 January 2021

Exploitation of the intestinal microflora by the parasitic nematode Trichuris muris

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930281-9

7 January 2021

Indications for propensity scores and review of their use in pharmacoepidemiology

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930281-9

7 January 2021

A review of the application of propensity score methods yielded increasing use, advantages in specific settings, but not substantially different estimates compared with conventional multivariable methods.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930281-9

7 January 2021

10.1016/S2213-8587(16)30281-9

Identifiers

DOI

1 reference

6 September 2017

1 reference